Saba Capital Management’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-437,676
Closed -$1.05M 544
2023
Q3
$1.05M Hold
437,676
0.03% 244
2023
Q2
$1.01M Sell
437,676
-18,779
-4% -$53K 0.03% 274
2023
Q1
$1.16M Sell
456,455
-404,895
-47% -$1.16M 0.02% 376
2022
Q4
$2.16M Buy
+861,350
New +$2.4M 0.03% 490

Other funds holding SLGC

Saba Capital Management's SLGC Position: Q4 2023 in Review

Saba Capital Management sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q4 2023, closing a stake of 437,676 shares — an estimated $1.05M sold.

Saba Capital Management first reported a position in SLGC in Q4 2022 and held it in 4 quarters. The position peaked at $2.16M in Q4 2022. 119 funds tracked by Wall St. Rank hold SLGC as of Q4 2023.

  • Saba Capital Management reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q4 2023 after selling out during the quarter.
  • Saba Capital Management sold 437,676 SomaLogic, Inc. Class A Common Stock shares in Q4 2023, an estimated $1.05M.
  • Saba Capital Management first reported a position in SomaLogic, Inc. Class A Common Stock in Q4 2022 and held it in 4 quarters.
  • Saba Capital Management's SomaLogic, Inc. Class A Common Stock position peaked at $2.16M in Q4 2022.
  • 119 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q4 2023.

Based on Saba Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.